Atlas Trials

IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals

Clinical trial NCT06963541 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06963541
Sponsor
Melahat Yalcin Solak
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
SepsisSeptic ShockInflammationBiomarkers
Start date
2025-05-15
Primary completion
2025-11-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.